logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Stocks > HK Stock

On April 8, CHINA RES GAS (01193) spent 21.2413 million Hong Kong dollars repurchasing 1.0932 million shares.

date
18:19 08/04/2026
avatar
GMT Eight
China Resources Gas (01193) announced that the company repurchased 1,093,200 shares for HKD 21.2413 million on April 8, 2026, with a repurchase price ranging from HKD 19.25 to 19.5 per share.
CHINA RES GAS (01193) announced that the company spent 21.2413 million Hong Kong dollars on April 8, 2026 to repurchase 1.0932 million shares, with a repurchase price of 19.25-19.5 Hong Kong dollars per share.
Related Articles
HK Stock
Billion Industries Holdings Limited (02299) spent 39,200 Hong Kong dollars to repurchase 8,000 shares on April 10th.
HK Stock
Yue Yuen Industries (00551) total comprehensive operating income for the first three months decreased by 2.2% year-on-year to 1.985 billion US dollars.
China Stock
Jiangsu Hengrui Pharmaceuticals (600276.SH): HRS-5765 tablets have obtained the drug clinical trial approval letter.
Billion Industries Holdings Limited (02299) spent 39,200 Hong Kong dollars to repurchase 8,000 shares on April 10th.
HK Stock
Yue Yuen Industries (00551) total comprehensive operating income for the first three months decreased by 2.2% year-on-year to 1.985 billion US dollars.
HK Stock
Jiangsu Hengrui Pharmaceuticals (600276.SH): HRS-5765 tablets have obtained the drug clinical trial approval letter.
China Stock
RECOMMEND
Deloitte China Reports Three Mega Hong Kong IPOs Among Global Top Five In Q1
Deloitte China Reports Three Mega Hong Kong IPOs Among Global Top Five In Q1
icon
09/04/2026
Token Wave Reshapes China’s Internet Landscape
Token Wave Reshapes China’s Internet Landscape
icon
09/04/2026
State‑Owned Six Banks Saw Consumer Loan Balances Rise Over RMB 55 Billion Last Year, Five Banks Grew Above 16% — Will The Surge Continue In 2026?
State‑Owned Six Banks Saw Consumer Loan Balances Rise Over RMB 55 Billion Last Year, Five Banks Grew Above 16% — Will The Surge Continue In 2026?
icon
09/04/2026
logo
Contact US
qr
+852 - 60190728
[email protected]
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.